Dosimetric Evaluations of Different Accelerator Based Treatment Modalities for Curative Intent Stereotactic Body Radiation Therapy of Isolated Thoracic Spinal Metastases
L. Ma,J. Yang,X. S. Wang,W. Xu,X. H. Kong,H. Yang,J. Y. Wang,S. P. Xu,Z. J. Ju,L. Du,B. N. Cai,C. C. Yang
DOI: https://doi.org/10.1016/j.ijrobp.2015.07.717
2015-01-01
Abstract:To investigate the dosimetric characteristics of 4 linear accelerator (LINAC) based stereotactic body radiation therapy (SBRT) modalities, CyberKnife (CK, Accuray), helical tomotherapy (HT, Accuray TomoTherapy system), double-arc volumetric modulated arc therapy (VMAT) performed with RapidArc system (RA, Varian) and step-and-shoot intensity modulated radiation therapy (sIMRT, Elekta Synergy S system) on isolated thoracic spinal metastasis . CK, HT, RA and sIMRT plans were cross compared in 10 patients with 6 body type and 6 body + pedicle type isolated thoracic metastases, with curative-intent prescription dose of 33 Gy/3F and 40 Gy/5F to covering ≥90% of the target volume, respectively. Different dosimetric indices, beam-on-time, and MUs were evaluated in details In ensuring the dose-volume constraints for cord and esophagus of the premise, CK, HT and RA achieved a sharp gradient index (GI) and a small penumbra volume compared to sIMRT. RA achieved a better conformity index (CI) compared to CK, HT and sIMRT. CK had a heterogeneous dose distribution in the target volume. CK occupied the longest beam-on-time and the highest MUs, followed by HT, sIMRT and RA with shortest and the least MUs. For the body type metastasis, CK, HT and RA satisfied the target coverage of ≥90% in all the 6 cases, but only in 3 cases (50%) by sIMRT. For the body + pedicle type metastasis, HT satisfied the criterion of the target coverage criterion in 4 out of the 6 cases, and reached target coverage of 89.0% in another case. The criterion of the target coverage was satisfied in 2 cases by CK and RA, but only in 1 case by sIMRT. For curative-intent SBRT with isolated thoracic spinal metastasis, RA is the common choice for the body type metastasis with current LINAC systems, then followed by CK or HT techniques if available; HT is the preferential choice for the body + pedicle type metastasis. This study suggests further clinical investigations to differential individual benefits.